Filter posts

Innovation Act Threatens Biotech Innovation

BIO has grave concerns regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee. …

TRIPs Has Delivered: Patent Agreement Increases Drug Development

The TRIPs (Trade Related Aspects of Intellectual Property) Agreement, effective in 1996, has resulted in …

Patents Improve Public Health: Progressive Economy Reviews TRIPS at 20 Years

Progressive Economy released a research paper examining the effect of TRIPS (Trade-Related Aspects of Intellectual …

Neglected Diseases: What if IP was the Cure?

The Lancet Global Health Journal recently published an article “The drug and vaccine landscape for …

South Africa National Policy on Intellectual Property: Inconsistent with Biotech Development Goals

BIO submitted comments this week to the government of South Africa on their proposed “Draft …

The "Designer Baby" Patent: Why the Patent System Should Not Regulate Science

23andMe received criticism this week from a few bioethicists in the journal Genetics in Medicine, …

JOBS Act Deconstructed: Regulation A

More than 40 biotech companies have gone public using provisions made available to emerging growth …

New Bill Calls for No WTO-Plus Benefits for Countries that Violate IP

A new Bill in the U.S. House of Representatives seeks to remove WTO-plus trade benefits …

“Should the USPTO allow the patenting of living organisms?”

Most people associate patents with mechanical or electronic devices, new chemical substances, intricate machines or …

India’s IP Policy: India’s Lead Biotech Innovator Expresses Concern

Kiran Mazumdar-Shaw, chairperson and managing director of India’s largest biotechnology company Biocon, expressed concern with …